Researchers developed a CRISPR-based system that spreads through bacterial populations to disable antibiotic resistance genes ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.

Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...

The sensor combines nanostructures made of DNA with quantum dots and CRISPR gene editing technology to detect biomarkers, ...

A new highly sensitive light-based sensor can detect extremely low concentrations of cancer biomarkers in the blood.

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...

A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.

Active Genetics (Pro-AG) exploits a naturally created bacterial mating tunnel between cells to inactivate antibiotic resistance.

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...